2007•Expert Opinion on Therapeutic PatentsRequires access

Antifilarial agents

Nisha Mathew, Muthuswami Kalyanasundaram

Open publisher page 11 citations

Abstract

Lymphatic filariasis and river blindness (onchocerciasis) are two important tropical diseases caused by infections with filarial nematodes, resulting in considerable morbidity. Onchocerciasis is caused by infection with the nematode worm Onchocerca volvulus, which is transmitted by blackflies. Lymphatic filariasis is caused by infection with the parasitic nematodes, Wuchereria bancrofti, Brugia malayi and B. timori transmitted by mosquito vectors. Onchocerciasis is presently treated with ivermectin, while the drugs used for lymphatic filariasis are diethylcarbamazine and ivermectin in combination with albendazole. None of these is effective in completely killing the long-lived adult worms (macrofilariae) and, therefore, treatments are aimed at reducing transmission and pathology. New drugs that affect new molecular targets are essential to improve treatment and control by killing the adult filarial worms. An exhaustive review on antifilarial drug development is presented here.

About this research paper

What this paper is about

Lymphatic filariasis and river blindness (onchocerciasis) are two important tropical diseases caused by infections with filarial nematodes, resulting in considerable morbidity. Onchocerciasis is caused by infection with the nematode worm Onchocerca volvulus, which is transmitted by blackflies. Lymphatic filariasis is caused by infection with the parasitic nematodes, Wuchereria bancrofti, Brugia malayi and B. timori transmitted by mosquito vectors. Onchocerciasis is presently treated with ivermectin, while the drugs used for lymphatic filariasis are diethylcarbamazine and ivermectin in combination with albendazole. None of these is effective in completely killing the long-lived adult worms (macrofilariae) and, therefore, treatments are aimed at reducing transmission and pathology. New drugs that affect new molecular targets are essential to improve treatment and control by killing the adult filarial worms. An exhaustive review on antifilarial drug development is presented here.

Why it matters

OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Lymphatic filariasis and river blindness (onchocerciasis) are two important tropical diseases caused by infections with filarial nematodes, resulting in considerable morbidity. Onchocerciasis is caused by infection with the nematode worm Onchocerca volvulus, which is transmitted by blackflies. Lymphatic filariasis is caused by infection with the parasitic nematodes, Wuchereria bancrofti, Brugia malayi and B. timori transmitted by mosquito vectors. Onchocerciasis is presently treated with ivermectin, while the drugs used for lymphatic filariasis are diethylcarbamazine and ivermectin in combination with albendazole. None of these is effective in completely killing the long-lived adult worms (macrofilariae) and, therefore, treatments are aimed at reducing transmission and pathology. New drugs that affect new molecular targets are essential to improve treatment and control by killing the adult filarial worms. An exhaustive review on antifilarial drug development is presented here.

Key concepts: Lymphatic filariasis, Onchocerciasis, Ivermectin, Brugia malayi, Onchocerca volvulus, Diethylcarbamazine, Wuchereria bancrofti, Filariasis

Related papers

Back to paper searchBrowse research topicsOriginal source
Antifilarial agents — Research Paper | ScholarLens